Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Spike-specific Cellular Immune Response After COVID-19 Vaccination

NCT05102669 is registered in ClinicalTrials.gov with IRCCS San Raffaele Roma as lead sponsor.

NCT NCT05102669
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05102669 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Spike-specific Cellular Immune Response After COVID-19 Vaccination
Lead sponsor
IRCCS San Raffaele Roma
Phase
Observational
Overall status
Completed
Start date
March 12, 2021
Completion date
October 11, 2021
Enrollment
53 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, immune response, vaccination